|
|
(21 dazwischenliegende Versionen von einem Benutzer werden nicht angezeigt) |
Zeile 1: |
Zeile 1: |
− | {{pnc}} __NOTOC__ | + | __NOTOC__ |
− | *'''[[Journal publishers collections|JOURNAL PUBLISHERS C-SITES]]'''
| + | {{gohome}} |
| + | {{ft|F}} |
| | | |
− | ===BOOKS===
| + | '''[[FR Disease Maps]]''' |
− | *[https://link.springer.com/book/10.1007/978-981-15-4814-7 Free Springer ebook] '''Coronavirus Disease 2019 (COVID-19)'''
| + | |
| | | |
| + | '''[[FR Books ]]''' |
| | | |
− | ===EDU STUFF===
| + | '''[[FR Edu Sites ]]''' |
− | {{tp|p=32222251|t=2020. A UK-wide British Society of Thoracic Imaging COVID-19 imaging repository and database: design, rationale and implications for education and research |pdf=|usr=}}
| + | |
− | {{tp|p=32479712|t=2020. An Online Educational Platform in the COVID-19 Pandemic.|pdf=|usr=008}}
| + | |
| | | |
| + | '''[[FR Databases ]]''' |
| | | |
− | ===DATABASES===
| + | '''[[FR Trial Sites ]]''' |
− | {{tp|p=23202522|t=2012. Virus Pathogen Database and Analysis Resource (ViPR): A Comprehensive Bioinformatics Database and Analysis Resource for the Coronavirus Research Community |pdf=|usr=}}
| + | |
− | {{tp|p=32352364|t=2020. Treatment of Severe Acute Respiratory Syndrome Coronavirus 2: It Is Time to Produce Our Own Evidence Base |pdf=|usr=}}
| + | |
− | *[https://www.gisaid.org/ GISAID database on covid19]
| + | |
− | *[https://covid.pages.uni.lu/ The COVID-19 Disease Map] is an assembly of molecular interaction diagrams, established based on literature evidence.We focus on host-pathogen interactions specific to the SARS-CoV-2 virus.] ''COVID-19 Disease Map, building a computational repository of SARS-CoV-2 virus-host interaction mechanisms. Ostaszewski M et al., Sci Data. 2020 May 5;7(1):136. doi: 10.1038/s41597-020-0477-8. PubMed PMID: 32371892. ''
| + | |
− | *[https://bigd.big.ac.cn/ncov?lang=en China National Center for Bioinformation 2019 Novel Coronavirus Resource (2019nCoVR)] 20k papers, 30k sequences, 200 clinical records ''Zhao WM, Song SH, Chen ML, et al. The 2019 novel coronavirus resource. Yi Chuan. 2020;42(2):212–221. doi:10.16288/j.yczz.20-030 [PMID: 32102777]'' {{tp|p=32102777|t=2020. The 2019 novel coronavirus resource |pdf=|usr=}} ''https://bigd.big.ac.cn/ncov''
| + | |
− | {{ttp|p=32442263|t=2020. It is time for computable evidence synthesis: The COVID-19 Knowledge Accelerator Initiative.|pdf=|usr=007}}
| + | |
| | | |
| + | '''[[FR Lit Arch Access ]]''' |
| | | |
− | ===TRIAL COLLECTORS===
| + | '''[[FR Preprint ]]''' |
− | *[https://www.trialsitenews.com/category/covid-19/ trialsitenews watch for anything in any pipeline]
| + | |
− | {{tp|p=32514563|t=2020. Anticovid, a comprehensive open-access real-time platform of registered clinical studies for COVID-19.|pdf=|usr=008}}
| + | |
| | | |
| + | '''[[FR Publication Ethics ]]''' |
| | | |
− | ===LIT ARCHIVES ACCESS===
| + | '''[[FR Retraction Record]]''' |
− | *'''[http://www.moremed.org/SiteSearch.php?S1=%28covid19+OR+covid-19+OR+covid19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov%29&S2=&S3=&submit=submit&px1=proxy.nationallizenzen.de&px2=&px3=&px4=&R=all&Y0=1500&Y1=2025 SEARCH PUBMED PMC]'''
| + | |
− | *'''[http://www.moremed.org/SiteSearch.php?S1=%28covid19+OR+covid-19+OR+covid19+OR+sars-cov2+OR+sars-cov-2+OR+2019-ncov+OR+2019ncov%29&S2=%28bioRXiv%5BJOUR%5D+OR+medRXiv%5BJOUR%5D+OR+chemRXiv%5BJOUR%5D%29&S3=&submit=submit&px1=proxy.nationallizenzen.de&px2=&px3=&px4=&R=all&Y0=1500&Y1=2025 SEARCH biorxiv, chemrxiv, medrxiv PREPRINT PUBMED]'''
| + | |
− | {{tp|p=32292015|t=2020. Features and Limitations of LitCovid Hub for Quick Access to Literature About COVID-19|pdf=|usr=}}
| + | |
− | {{tp|p=32362782|t=2020. Aktuelle Informationen zu COVID-19 auf einer Plattform ? zeitschriftenübergreifend |pdf=|usr=}}
| + | |
− | {{tp|p=32092748|t=2020. COVID-19: Real-time dissemination of scientific information to fight a public health emergency of international concern |pdf=|usr=}}
| + | |
− | {{ttp|p=32327431|t=2020. Keeping up with studies on covid-19: systematic search strategies and resources |pdf=|usr=}}
| + | |
− | {{tp|p=32358556|t=2020. Coronavirus in context: Scite ai tracks positive and negative citations for COVID-19 literature |pdf=|usr=}}
| + | |
− | {{tp|p=32157233|t=2020. Keep up with the latest coronavirus research |pdf=|usr=}}
| + | |
− | {{tp|p=32251543|t=2020. The COVID-19 (Coronavirus) pandemic: reflections on the roles of librarians and information professionals |pdf=|usr=}}
| + | |
− | {{tp|p=32369539|t=2020. Keeping Up With Emerging Evidence in (Almost) Real Time.|pdf=|usr=008}}
| + | |
− | {{tp|p=32467369|t=2020. New tools aim to tame pandemic paper tsunami.|pdf=|usr=008}}
| + | |
| | | |
− | ===PREPRINT===
| + | '''[[FR Linklists ]]''' |
− | *[https://outbreaksci.prereview.org/ X-rxiv preprint scanner, ]
| + | |
− | {{tp|p=32379021|t=2020. Rapid Publication, Knowledge Sharing, and Our Responsibility During the COVID-19 Pandemic |pdf=|usr=}}
| + | |
| | | |
| + | '''[[Journal publishers collections]]''' |
| | | |
− | ===ALLYOUNEED SITES===
| + | '''[[FR Tell-me Sites ]]''' |
− | {{tp|p=32419941|t=2020. EAHP launches COVID-19 resource centre for hospital pharmacists.|pdf=|usr=007}}
| + | |
− | {{ttp|p=32484782|t=2020. Oxford Royal College of General Practitioners Clinical Informatics Digital Hub: Rapid innovation to deliver extended COVID-19 surveillance and trial platforms.|pdf=|usr=007}}
| + | |
− | {{tp|p=32358176|t=2020. SNMMI COVID-19 Resource Center.|pdf=|usr=007}}
| + | |
− | {{tp|p=32511054|t=2020. COVID-19 Digital Health Innovation Policy: A Portal to Alternative Futures in the Making.|pdf=|usr=007}}
| + | |
− | {{tp|p=32394481|t=2020. Genesis of an emergency public drug information website by the French Society of Pharmacology and Therapeutics during the COVID-19 pandemic.|pdf=|usr=008}}
| + | |
− | {{tp|p=32493339|t=2020. Amplifying the role of knowledge translation platforms in the COVID-19 pandemic response.|pdf=|usr=008}}
| + | |
− | {{tp|p=32437931|t=2020. On the crucial role of multilingual biomedical databases in epidemic events (SARS-CoV-2 analysis).|pdf=|usr=008}}
| + | |
− | *[[https://www.nhs.uk/conditions/coronavirus-covid-19/ NHS covidsite]]
| + | |
| | | |
− | ===WEBSITES LINKLISTS===
| + | '''[[Social media covid19 ]]''' |
− | *[https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7187738/?report=classic big link list published as a paper]
| + | |
| | | |
− | ===publication questions===
| |
− | {{tp|p=32466477|t=2020. Research Progress of Coronavirus Based on Bibliometric Analysis.|pdf=|usr=007}}
| |
− | {{tp|p=32481379|t=2020. The status and trends of coronavirus research: A global bibliometric and visualized analysis.|pdf=|usr=007}}
| |
− | {{tp|p=32503819|t=2020. Coronavirus Disease (COVID-19): A Machine Learning Bibliometric Analysis.|pdf=|usr=007}}
| |
− | {{tp|p=32495576|t=2020. [Visual analysis of coronavirus disease 2019 (COVID-19) studies based on bibliometrics].|pdf=|usr=007}}
| |
− | {{tp|p=32408679|t=2020. Identifying Research Trends and Gaps in the Context of COVID-19.|pdf=|usr=007}}
| |
− | {{tp|p=32462703|t=2020. The COVID-19 epidemic of manuscripts.|pdf=|usr=007}}
| |
− | {{tp|p=32458963|t=2020. Constructing Co-occurrence Network Embeddings to Assist Association Extraction for COVID-19 and Other Coronavirus Infectious Diseases.|pdf=|usr=007}}
| |
− | {{tp|p=32411751|t=2020. COVID-19 will stimulate a new coronavirus research breakthrough: a 20-year bibliometric analysis.|pdf=|usr=008}}
| |
− | {{tp|p=32315261|t=2020. Information Overload: A Method to Share Updates among Frontline Staff during the COVID-19 Pandemic.|pdf=|usr=007}}
| |
− | {{tp|p=32474933|t=2020. Rapid publishing in the era of coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
| |
− | {{tp|p=32474929|t=2020. Rapid publishing in the era of coronavirus disease 2019 (COVID-19).|pdf=|usr=007}}
| |
− | {{tp|p=32396623|t=2020. Social media and the new world of scientific communication during the COVID19 pandemic.|pdf=|usr=008}}
| |
− | {{tp|p=32294236|t=2020. Exaggerated information and COVID-19 outbreak.|pdf=|usr=008}}
| |
− | {{tp|p=32293030|t=2020. Letter to the Editor Re: Coronavirus disease 2019: The harms of exaggerated information and nonevidence-based measures.|pdf=|usr=008}}
| |
− | {{tp|p=32350859|t=2020. Redundancy in reporting on COVID-19.|pdf=|usr=008}}
| |
− | {{tp|p=32431291|t=2020. Rapid reviews for rapid decision-making during the coronavirus disease (COVID-19) pandemic, Norway, 2020.|pdf=|usr=008}}
| |
− | {{tp|p=32246722|t=2020. Coronavirus SARS-CoV-2: filtering fact from fiction in the infodemic: Q&A with virologist Professor Urs Greber.|pdf=|usr=008}}
| |
− | {{tp|p=32429885|t=2020. Keeping up with the information explosion: a surge in consumption of data on pediatric SARS-CoV-2 infection by pediatric emergency physicians.|pdf=|usr=008}}
| |
− | {{tp|p=32521776|t=2020. Studies of Novel Coronavirus Disease 19 (COVID-19) Pandemic: A Global Analysis of Literature.|pdf=|usr=008}}
| |
− | {{tp|p=32447127|t=2020. COVID-19 pandemic, infodemic and the role of eHealth literacy.|pdf=|usr=008}}
| |
− | {{tp|p=32365190|t=2020. TREC-COVID: Rationale and Structure of an Information Retrieval Shared Task for COVID-19.|pdf=|usr=008}}
| |
− | {{tp|p=32427189|t=2020. Global health crises are also information crises: A call to action.|pdf=|usr=008}}
| |
− | {{tp|p=32405191|t=2020. Unprecedented surge in publications related to COVID-19 in the first three months of pandemic: A bibliometric analytic report.|pdf=|usr=008}}
| |
− | {{tp|p=32533803|t=2020. The Covid-19 'infodemic': a new front for information professionals.|pdf=|usr=008}}
| |
| | | |
− | ===RETRACTED PAPERS===
| + | '''[[ ]]''' |
− | {{tp|p=32479106|t=2020. Notice of Retraction: Effectiveness of Surgical and Cotton Masks in Blocking SARS-CoV-2.|pdf=|usr=008}}
| + | |
− | {{tp|p=32062875|t=2020. [Retracted: Clinical and epidemiological characteristics of 34 children with 2019 novel coronavirus infection in Shenzhen].|pdf=|usr=008}}
| + | |
− | {{tp|p=32133832|t=2020. [WITHDRAWN: Potential false-positive rate among the 'asymptomatic infected individuals' in close contacts of COVID-19 patients].|pdf=|usr=008}}
| + | |
− | {{tp|p=32425336|t=2020. WITHDRAWN: Analysis of thin-section CT in patients with coronavirus disease (COVID-19) after hospital discharge|pdf=|usr=008}}
| + | |
− | | + | |
− | to be added:
| + | |
− | | + | |
− | * 1 x lancet
| + | |
− | * 1 x nejm (96000 on chlq)
| + | |
− | | + | |
− | ===PUT IDEAS===
| + | |
− | | + | |
− | *[[Ppl who want to hear your ideas on covid19]]
| + | |
− | *[[Social media covid19]]
| + | |
− | | + | |
− | *'''something'''
| + | |
− | {{tp|p=32336688|t=2020. Does a Crying Child Enhance the Risk for COVID-19 Transmission?|pdf=|usr=}}
| + | |
− | {{tp|p=32402184|t=2020. Audio Interview: Finding Reliable Information about Covid-19.|pdf=|usr=007}}
| + | |
− | *[https://www.xcdsystem.com/uscap/program/eJ02pRV/index.cfm?pgid=3833 webinar on pulmonary pathology uscap]
| + | |
− | | + | |
− | | + | |
− | ===000===
| + | |
− | | + | |
− | | + | |
− | {{tp|p=32275296|t=2020. Data Error in Viewpoint on COVID-19 in Italy.|pdf=|usr=009}}
| + | |
− | {{tp|p=32504543|t=2020. Expression of concern: Hydroxychloroquine or chloroquine with or without a macrolide for treatment of COVID-19: a multinational registry analysis.|pdf=|usr=009}}
| + | |
− | {{tp|p=32113504|t=2020. Retraction-Chinese medical staff request international medical assistance in fighting against COVID-19.|pdf=|usr=009}}
| + | |
− | {{tp|p=32501665|t=2020. Retraction: Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.|pdf=|usr=009}}
| + | |
− | {{tp|p=32484612|t=2020. Expression of Concern: Mehra MR et al. Cardiovascular Disease, Drug Therapy, and Mortality in Covid-19. N Engl J Med. DOI: 10.1056/NEJMoa2007621.|pdf=|usr=009}}
| + | |
− | {{tp|p=32502638|t=2020. Databases for facilitating mechanistic investigations of traditional Chinese medicines against COVID-19.|pdf=|usr=009}}
| + | |
− | {{tp|p=32425198|t=2020. North American COVID-19 ST-segment elevation myocardial infarction (NACMI) registry: Rationale, design, and implications.|pdf=|usr=008}}
| + | |
− | {{tp|p=32429681|t=2020. COVID-19 (Coronavirus) Pandemic: Information Sources Channels for the Public Health Awareness.|pdf=|usr=008}}
| + | |
− | {{tp|p=32398883|t=2020. The COVID-19 Virtual Idea Blitz: Marshaling social entrepreneurship to rapidly respond to urgent grand challenges.|pdf=|usr=008}}
| + | |
− | {{tp|p=32450197|t=2020. Extra-respiratory manifestations of COVID-19.|pdf=|usr=008}}
| + | |
− | {{tp|p=32159254|t=2020. Where are we now with COVID-19?|pdf=|usr=008}}
| + | |
− | {{tp|p=32530738|t=2020. Decrease in Hospital Admissions for Transient Ischemic Attack, Mild, and Moderate Stroke During the COVID-19 Era.|pdf=|usr=008}}
| + | |
− | {{tp|p=32407043|t=2020. Rapid Expert Consultations on the COVID-19 Pandemic: March 14, 2020-April 8, 2020|pdf=|usr=007}}
| + | |
− | {{tp|p=32246113|t=2020. COVID-19 Research in Brief: 28 March to 3 April, 2020.|pdf=|usr=007}}
| + | |
− | {{tp|p=32385366|t=2020. Coronavirus diaries: all the things we do not do.|pdf=|usr=007}}
| + | |
− | {{tp|p=32444822|t=2020. Coronavirus diaries: finding a place to have new ideas.|pdf=|usr=007}}
| + | |
− | {{tp|p=32036011|t=ä. Coronavirus infections reported by ProMED, February 2000?January 2020 |pdf=|usr=}}
| + | |
− | {{tp|p=32371551|t=2020. The COronavirus Pandemic Epidemiology (COPE) Consortium: A Call to Action.|pdf=|usr=007}}
| + | |
− | | + | |
− | ===010===
| + | |
− | | + | |
− | {{tp|p=32553912|t=2020. Protective equipment to use in the vaginal delivery of the pregnant women with suspected/diagnosed COVID-19:Delivery Table Shield.|pdf=|usr=010}}
| + | |
− | {{tp|p=32586327|t=2020. Rapid publications risk the integrity of science in the era of COVID-19.|pdf=|usr=010}}
| + | |
− | {{tp|p=32571302|t=2020. Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19.|pdf=|usr=010}}
| + | |
− | {{tp|p=32588336|t=2020. Assessing the reading level of online resources on COVID-19.|pdf=|usr=010}}
| + | |
− | {{tp|p=32538544|t=2020. Health information professionals: delivering core services and value in extraordinary times.|pdf=|usr=010}}
| + | |
− | {{tp|p=32571364|t=2020. How to strengthen a health research system: WHO's review, whose literature and who is providing leadership?|pdf=|usr=010}}
| + | |
− | {{tp|p=32589695|t=2020. An Alert to COVID-19 Literature in Predatory Publishing Venues.|pdf=|usr=010}}
| + | |
− | {{tp|p=32555466|t=2020. COVIDep: a web-based platform for real-time reporting of vaccine target recommendations for SARS-CoV-2.|pdf=|usr=010}}
| + | |
− | {{tp|p=32579869|t=2020. Validate the Integrity of Research Data on COVID 19.|pdf=|usr=010}}
| + | |
− | {{tp|p=32573274|t=2020. An alarming retraction rate for scientific publications on Coronavirus Disease 2019 (COVID-19).|pdf=|usr=010}}
| + | |
− | {{tp|p=32543229|t=2020. Luxembourg's Approach to Research Integrity during the COVID-19 Pandemic.|pdf=|usr=010}}
| + | |
− | {{tp|p=32591333|t=2020. Covid-19: scientific advisers must do more than just voice their concerns behind closed doors.|pdf=|usr=010}}
| + | |
− | {{tp|p=32571547|t=2020. Trends of publications during COVID-19 pandemic.|pdf=|usr=010}}
| + | |
− | {{tp|p=32562840|t=2020. International Collaboration and Rapid Harmonization across Dermatologic COVID-19 Registries.|pdf=|usr=010}}
| + | |
− | {{tp|p=32561147|t=2020. A Framework for Evidence Synthesis Programs to Respond to a Pandemic.|pdf=|usr=010}}
| + | |
− | {{tp|p=32576981|t=2020. Pandemic publishing poses a new COVID-19 challenge.|pdf=|usr=010}}
| + | |